Osiyan Lifescience Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.30 M
as on 13-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 7.00 M
as on 13-12-2024
- Revenue -17.49%
(FY 2021)
- Profit 0.14%
(FY 2021)
- Ebitda 137.06%
(FY 2021)
- Net Worth 61.56%
(FY 2021)
- Total Assets -32.60%
(FY 2021)
About Osiyan Lifescience
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.30 M.
The company currently has active open charges totaling ₹7.00 M.
Savita and Kirthi Jain serve as directors at the Company.
- CIN/LLPIN
U85320KA2016PTC092895
- Company No.
092895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Osiyan Lifescience Private Limited offer?
Osiyan Lifescience Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Skin Toner, Body Cream, Immunity Boosters, Vitamin C.
Who are the key members and board of directors at Osiyan Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita  | Director | 04-May-2016 | Current |
| Kirthi Jain | Director | 04-May-2016 | Current |
Financial Performance of Osiyan Lifescience.
Osiyan Lifescience Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.49% decrease. The company also saw a slight improvement in profitability, with a 0.14% increase in profit. The company's net worth Soared by an impressive increase of 61.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Osiyan Lifescience?
In 2021, Osiyan Lifescience had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 21 Jan 2023 | ₹7.00 M | Open |
How Many Employees Work at Osiyan Lifescience?
Unlock and access historical data on people associated with Osiyan Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Osiyan Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Osiyan Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
